Kyverna Therapeutics (KYTX) Return on Assets (2024 - 2026)

Kyverna Therapeutics' Return on Assets history runs 3 years deep, the most recent figure standing at 0.01% for Q1 2026.

• Quarterly Return on Assets changed 0.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, changed 0.0% from the prior year.
• Return on Assets was 0.01% for Q1 2026 at Kyverna Therapeutics, down from 0.01% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q2 2024 and bottomed at 0.01% in Q3 2025.
• A 3-year average of 0.01% and a median of 0.01% in 2025 frame the typical range for Return on Assets.
• Peak annual rise in Return on Assets reached 0 bps in 2025, while the deepest fall reached 1 bps in 2025.
• Kyverna Therapeutics' Return on Assets stood at 0.0% in 2024, then tumbled by 60 bps to 0.01% in 2025, then fell by 1 bps to 0.01% in 2026.
• Business Quant data shows KYTX's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.